medigraphic.com
Boletín Médico del Hospital Infantil de México

2019, Number 4

<< Back Next >>

Bol Med Hosp Infant Mex 2019; 76 (4)

Acute gastroenteritis due to norovirus in patients with hospital care: a cross-sectional study

Cervantes-Izaguirre AP, Rendón-Macías ME, Martina-Luna M, Iglesias-Leboreiro J, Bernárdez-Zapata I, Martínez-Hernández A

Language: Spanish
References: 29
Page: 176-181
PDF size: 109.09 Kb.


ABSTRACT

Background: Because of the availability of molecular techniques in clinical care, acute gastroenteritis (AGE) due to norovirus has returned to importance as a causative agent of hospitalization. The aim of this study was to describe the clinical features and evolution of patients less than 16 years hospitalized for AGE associated with norovirus. Methods: Retrospective study. Clinical information of the patients attended from November 1, 2016 to February 28, 2018 by AGE with detection of norovirus (genotype I and II) in faeces by means of polymerase chain reaction with reverse transcriptase was collected. Results: We studied 103 patients; 96 (93.2%; 95% confidence interval [95% CI]: 86.6-96.7%) with genotype II detection and seven (6.8%; 95% CI: 5.3-8.7%) genotype I; 76 (73.8%) ≤5 years. 48.5% attended during the winter. The evolution was to self-limitation in less than 7 days in all with hydro electrolytic management. There were no differences in the severity and symptoms according to the viral group; in both cases the vomiting predominated (82%). Only one patient had intestinal perforation due to co-infection with Shigella sp.; three patients (3.1%) manifested seizures (two febrile and one epileptic convulsions). Conclusions: Despite causing a meritorious disease of hospitalization, GEA by norovirus has a favorable prognosis with rapid self-limitation. Its timely detection by rapid tests in feces could avoid the unjustified prescription of antibiotics.


REFERENCES

  1. Naghavi M, Abajobir AA, Abbafati C, Abbas KM, Abd-Allah F, Abera SF, et al. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1151-210.

  2. Guarino A, Ashkenazi S, Gendrel D, Lo Vecchio A, Shamir R, Szajewska H, European Society for Pediatric Gastroenterology, Hepatology, and Nutrition; European Society for Pediatric Infectious Diseases. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: update 2014. J Pediatr Gastroenterol Nutr. 2014;59:132-52.

  3. Tran A, Talmud D, Lejeune B, Jovenin N, Renois F, Payan C, et al. Prevalence of rotavirus, adenovirus, norovirus, and astrovirus infections and coinfections among hospitalized children in northern France. J Clin Microbiol. 2010;48:1943-6.

  4. Friesema IHM, Boer RF, Duizer E, Kortbeek LM, Notermans DW, Norbruis OF, et al. Etiology of acute gastroenteritis in children requiring hospitalization in the Netherlands. Eur J Clin Microbiol Infect Dis. 2012;31:405-15.

  5. Li CSY, Chan PKS, Tang JW. Prevalence of diarrhea viruses in hospitalized children in Hong Kong in 2008. J Med Virol. 2009;81:1903-11.

  6. Ca Jacob NJ, Cohen MB. Update on diarrhea. Pediatr Rev. 2016;37: 313‑22.

  7. Hernández-Cortez C, Aguilera Arreola MG, Castro-Escarpulli G. Situación de las enfermedades gastrointestinales en México. Enf Inf Microbiol. 2011;31:137-51.

  8. Hassan F, Kanwar N, Harrison CJ, Halasa NB, Chappell JD, Englund JA, et al. Viral etiology of acute gastroenteritis in < 2-year-old US children in the post–rotavirus vaccine era. J Pediatr Infect Dis Soc [Internet]. 2018 [citado octubre 2018]. Disponible en: https://academic.oup.com/jpids/ advance-article/doi/10.1093/jpids/piy077/5090096.

  9. López-Medina E, Parra B, Dávalos DM, López P, Villamarín E, Pelaez M. Acute gastroenteritis in a pediatric population from Cali, Colombia in the post rotavirus vaccine era. Int J Infect Dis. 2018;73:52-9.

  10. Bányai K, Estes MK, Martella V, Parashar UD. Viral gastroenteritis. Lancet. 2018;392:175-86.

  11. Canales RA, Reynolds KA, Wilson AM, Fankem SLM, Weir MH, Rose JB, et al. Modeling the role of fomites in a norovirus outbreak. J Occup Environ Hyg. 2019;16:16-26.

  12. Nordgren J, Svensson L. Genetic susceptibility to human norovirus infection: an update. Viruses. 2019;11:226.

  13. Peasey AE, Ruiz-Palacios GM, Quigley M, Newsholme W, Martinez J, Rosales G, et al. Seroepidemiology and risk factors for sporadic norovirus/ Mexico strain. J Infect Dis. 2004;189:2027-36.

  14. Biscaro V, Piccinelli G, Gargiulo F, Ianiro G, Caruso A, Caccuri F, et al. Detection and molecular characterization of enteric viruses in children with acute gastroenteritis in Northern Italy. Infect Genet Evol. 2018; 60:35‑41.

  15. Burke RM, Shih S-M, Yen C, Huang Y-C, Parashar UD, Lopman BA, et al. Burden of severe norovirus disease in Taiwan, 2003-2013. Clin Infect Dis [Internet]. 2018; 67:1373-8. Disponible en: https://academic. oup.com/cid/advance-article/doi/10.1093/cid/ciy298/5033797.

  16. Bierhoff M, Arvelo W, Estevez A, Bryan J, McCracken JP, López MR, et al. Incidence and clinical profile of norovirus disease in Guatemala, 2008–2013. Clin Infect Dis. 2018;67:430-6.

  17. Luminex. Disponible en: www.luminexcorp.com/eu/aries-norovirus-assay.

  18. Ruuska T, Vesikari T. Rotavirus disease in Finnish chidren: use of numerical scores for clinical severity of diarrhoeal episodes. Scand J Infect Dis. 1990;22:259-67.

  19. García-Magán C, de Castro-López MJ, Llovo-Taboada J, Curros-Novo C, Puente-Puig M, Sánchez-Fauquier A, et al. Caracterización microbiológica de las gastroenteritis agudas virales atendidas en un servicio de pediatría en un área de alta cobertura vacunal frente a rotavirus. Enferm Infecc Microbiol Clin. 2014;32:246-9.

  20. Bonkoungou IJO, Ouédraogo N, Tamini L, Teguera RK, Yaméogo P, Drabo MK, et al. Rotavirus and norovirus in children with severe diarrhea in Burkina Faso before rotavirus vaccine introduction. J Med Virol. 2018; 90:1453-60.

  21. Siafakas N, Zerva L, Hatzaki D, Lebessi E, Chronopoulou G, Paraskakis I, et al. Molecular epidemiology of noroviruses in children in South Greece, 2013-2015. J Med Virol. 2018;90:1703-11.

  22. Biçer S, Cöl D, Küçük Ö, Erdağ GC, Giray T, Uğraş M, et al. Is there any difference between the symptomatology and clinical findings of viral agents causing dehydration? Minerva Pediatr. 2018;70:165-74.

  23. Xie J, Nettel-Aguirre A, Lee BE, Chui L, Pang XL, Zhuo R, et al. Relationship between enteric pathogens and acute gastroenteritis disease severity: a prospective cohort study. Clin Microbiol Infect. 2019;25:454‑61.

  24. Esteves A, Nordgren J, Tavares C, Fortes F, Dimbu R, Saraiva N, et al. Genetic diversity of norovirus in children under 5 years of age with acute gastroenteritis from Angola. Epidemiol Infect. 2018;146:551-7.

  25. Makhaola K, Moyo S, Lechiile K, Goldfarb DM, Kebaabetswe LP. Genetic and epidemiological analysis of norovirus from children with gastroenteritis in Botswana, 2013–2015. BMC Infect Dis. 2018;18:246.

  26. Kim BR, Choi GE, Kim YO, Kim MJ, Song ES, Woo YJ. Incidence and characteristics of norovirus-associated benign convulsions with mild gastroenteritis, in comparison with rotavirus ones. Brain Dev. 2018;40:699‑706.

  27. Farsi M, Roodbari F, Nejati B, Arashkia A, Jalilvand S, Nateghian A, et al. Prevalence and genetic diversity of norovirus genogroup II in children less than 5 years of age with acute gastroenteritis in Tehran, Iran. Med Microbiol Immunol. 2018;207:201-10.

  28. Hernández-Avendaño Y, Díaz-Madero S, Rendón-Macías ME, Iglesias- Leboreiro J, Bernárdez-Zapata I. Conducta terapéutica de los médicos ante el resultado de las pruebas de detección de patógenos en niños con diarrea aguda. Rev Mex Pediatr. 2018;85:5-10.

  29. Mattison CP, Cardemil CV, Hall AJ. Progress on norovirus vaccine research: public health considerations and future directions. Expert Rev Vaccines. 2018;17:773-84.




2020     |     www.medigraphic.com